LLY240809P855000
- 0.01
- -15.89-99.94%
Eli Lilly and Co Newsroom
Eli Lilly Logs Higher H1 Profit; Revenue Jumps
The Score: Apple, Walt Disney, Eli Lilly and More Stocks That Defined the Week -- WSJ
Wall Street Today | Flat Market To Finish Wild Week
S&P 500 Erases Weekly Losses, Nasdaq 100 Ends 4-Week Slide As Bulls Regain Momentum: Friday's Stock Movers At The Close
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
Eli Lilly's Assurances on Key GLP-1 Drugs Should Ease Investor Concerns, UBS Says
Sector Update: Health Care Stocks Rise in Friday Afternoon Trading
Trending Stocks Today | FSD Pharma Soars 200.22%
Sector Update: Health Care
Healthcare Stocks Are Turning Around. Here Are the Latest Winners. -- Barrons.com
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
'Don't Overreact to Market Volatility': Strategist
Eli Lilly Price Target Raised to $1000.00/Share From $875.00 by Wells Fargo
Eli Lilly +5%, Named 'Top Pick' Following Q2 Beat Morgan Stanley Says
Moovin Stonks | Friday Market Calm Before Storm After Turbulent Week
What Eli Lilly, Novo Nordisk Earnings Show About GLP-1 Sales
Analyzing Eli Lilly In Comparison To Competitors In Pharmaceuticals Industry
U.S. stock market anomaly | Weight loss concept stocks rise, Eli Lilly and Co (LLY.US) rose more than 6.8%.
As of press time, the stock rose more than 6.8%, reporting $903.
Redburn Atlantic Adjusts Eli Lilly Price Target to $640 From $600